Suppression of Androgen-Independent Prostate Cancer Cell Aggressiveness by FTY720: Validating Runx2 as a Potential Antimetastatic Drug Screening Platform
Chua, C.-W., Chiu, Y.-T., Yuen, H.-F., Chan, K.-W., Man, K., Wang, X., Ling, M.-T., Wong, Y.-C.Volume:
15
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-08-3157
Date:
July, 2009
File:
PDF, 879 KB
english, 2009